Apr 09, 2020
Abbott's TriClip(TM) Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
Mar 05, 2020
Cardiac Dimensions Hires Gretchen Gary As Vice President Of Global Therapy Development
Feb 25, 2020
New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation
Jan 30, 2020
Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
Jan 13, 2020
Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients
Jan 10, 2020
AVVie GmbH Austria ("Angel Valve") Achieved Important Milestone Completing 90 Days Chronic Animal Trial for Their Mitral Butterfly® Design
Sep 30, 2019
AltaValve(TM), 4C Medical's Novel Transcatheter Mitral Regurgitation Device Highlighted at TCT 2019
Sep 29, 2019
Late-Breaking Data Shows Abbott's MitraClip(TM) is Cost Effective, Increases Life Expectancy and Improves Quality of Life
Jul 15, 2019
Abbott Receives U.S. Approval of Next-Generation MitraClip®, Bringing New Enhancements to Abbott's Leading MitraClip Platform
May 21, 2019
TRILUMINATE Study Shows Treatment with Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks
Apr 26, 2019
New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation
Mar 17, 2019
New Late-Breaking Analyses from Landmark COAPT(TM) Trial Show Benefits of Abbott's MitraClip(TM) Device
Mar 14, 2019
Abbott Receives FDA Approval for Expanded Indication for MitraClip(TM) Device
Mar 14, 2019
FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation
Mar 06, 2019
Late-Breaking Data Presentations at ACC 2019 Highlight Abbott's Leading Cardiovascular Portfolio
Feb 25, 2019
4C Medical's Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2019 Meeting
Jan 30, 2019
Global Structural Heart Devices Market 2018-2024: Many Players in the Market are Flooding into the TMVR Arena
Jan 16, 2019
Abbott To Acquire Cephea Valve Technologies, Inc.
Sep 23, 2018
Landmark Study Shows Treatment with Abbott's MitraClip® is Superior to Medical Therapy for Advanced Heart Failure Patients with Significant Secondary Mitral Regurgitation
Jul 26, 2018
Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease